Sicca: Causes, Common Regions, and Potential Treatments

Sicca is a medical term for persistent, pathological dryness of mucous membranes and glands, most often affecting the eyes and mouth but capable of reaching the skin, nasal passages, throat, and genital tract. The dryness can stem from autoimmune disease, medication side effects, radiation therapy, aging, or environmental exposure, and in many patients several of these causes overlap. Because the symptoms touch so many body regions and daily activities, sicca tends to carry a heavier burden on quality of life than most people expect from something that sounds as simple as “dryness.”

How Autoimmune Disease Drives Sicca

The most studied cause of sicca is Sjögren’s disease, a chronic autoimmune condition in which the body’s immune cells infiltrate and gradually destroy the glands that produce tears and saliva. In Sjögren’s, immune cells cluster around the ducts of these glands and, over time, can replace the tissue that actually makes secretions. The targets of the immune attack include proteins on the surface of gland cells, and the resulting tissue injury leads to a progressive drop in tear and saliva output.¹ The clinical picture ranges from mild dryness to severe systemic disease with immune-complex deposits in multiple organs, and in a small subset of patients, lymphoma.²

Sjögren’s is not the only autoimmune culprit. Sarcoidosis can cause swelling and dysfunction of the parotid and submandibular glands, leading to dry mouth. Chronic graft-versus-host disease, which occurs after stem-cell transplants, frequently targets the mouth as one of its primary sites. Diabetes, end-stage kidney disease, and several other systemic conditions are also associated with reduced salivary output.³ In practice, many patients with sicca symptoms never receive a single neat diagnostic label because their dryness results from a combination of disease, medication, and age-related gland decline happening at the same time.

Medications as a Common and Underappreciated Cause

Drug-induced dryness is probably the most frequent reason someone develops sicca outside of an autoimmune diagnosis. Anticholinergic medications, a broad class that includes certain antidepressants, bladder drugs, antihistamines, and antipsychotics, block nerve signals that tell glands to secrete. Dry mouth shows up in roughly one in five to one in three people taking these drugs, according to clinical trials and a meta-analysis of 26 studies.⁴ In older adults, who often take multiple medications at once, the anticholinergic load is cumulative. A systematic review found a consistent positive relationship between the total anticholinergic burden a person carries and the likelihood of dry mouth and dry eyes.⁵

Eyes take a hit from medications too. Both systemic drugs and topical eye drops (including the preservatives used in many over-the-counter drops) can reduce tear production or destabilize the tear film. The effects of multiple medications are thought to be additive, so a person on an antihistamine, a blood-pressure drug, and preserved eye drops for glaucoma could be getting dry-eye contributions from all three at once.⁶ If you suspect a medication is behind your dryness, a pharmacist or prescriber can often identify which drugs on your list carry anticholinergic activity and whether alternatives exist.

Radiation, Aging, and Environmental Triggers

Head and neck cancer patients who undergo radiation therapy face a particularly harsh form of sicca. Radiation damages salivary glands both directly and through injury to the tiny blood vessels that feed them. Even with modern gland-sparing techniques and adjusted dosing, long-term salivary loss remains a significant problem, and current treatments provide only temporary symptom relief without reversing the underlying glandular damage.⁷ Research in animal models has shown that the vascular damage involves ceramide production and reactive oxygen species, and that antioxidant pretreatment can partially protect gland function, though this has not yet translated into routine clinical use.⁸

Aging alone changes the glands that keep your eyes wet. The lacrimal gland gradually loses its nerve supply and secretory capacity over the decades. Immune cells infiltrate the gland tissue, ducts widen, and the volume and composition of tears shift, contributing to the high prevalence of dry eye among older adults.⁹

Environmental and lifestyle factors layer on top of whatever biological vulnerability a person already has. A cross-sectional study found that prolonged computer use carried about double the odds of dry eye symptoms compared with people without that exposure. Particulate matter, low humidity, wind and dust, and chemical irritants all showed elevated odds ratios as well.¹⁰ Extended screen time reduces blink rate and leads to incomplete blinking, which accelerates tear evaporation. These effects get worse in air-conditioned or heated offices where humidity is already low.¹¹

Where Sicca Shows Up in the Body

Most people associate sicca with dry eyes and dry mouth, and those are the two flagship sites. But the dryness can extend much further, and knowing that helps patients and clinicians connect seemingly unrelated complaints to a single underlying problem.

Eyes

Dry eye disease in the context of sicca is driven by inflammation of the ocular surface and the lacrimal gland, dysfunction of the oil-producing glands along the eyelid margin, and in some cases reduced nerve signaling to the tear-production apparatus.¹² In Sjögren’s disease specifically, dry eye affects up to 95 percent of patients and is often the earliest and most persistent symptom, involving tear film instability, corneal surface damage, and chronic inflammation.¹³ Symptoms include grittiness, burning, light sensitivity, and fluctuating vision.

Mouth

Saliva does far more than keep the mouth comfortable. It buffers acids, fights bacteria, and helps repair the earliest stages of tooth decay. When saliva drops, the consequences cascade: chewing becomes difficult, swallowing is impaired, taste changes, and speech can be affected. Oral yeast infections become common because the protective antimicrobial properties of saliva are lost. The risk of cavities and dental erosion climbs sharply.¹⁴ Many patients with chronic dry mouth end up altering their diet to softer, wetter foods, which sometimes means less nutritional variety.

Skin, Nose, Throat, and Genital Tract

In Sjögren’s disease, dryness frequently extends to the nose, the windpipe, the vagina, and the skin, suggesting that glands beyond the salivary and lacrimal are involved. Skin manifestations are relatively common and include generalized dryness, eyelid inflammation, and in some patients vascular changes.¹⁵ Vaginal dryness, often underreported because of embarrassment, has been confirmed with tissue analysis: vaginal biopsies from women with Sjögren’s show increased immune cell infiltrates and decreased smooth muscle in blood vessel walls compared with controls.¹⁶ This dryness is not merely a discomfort issue; it affects sexual health, urinary function, and potentially long-term genital health.¹⁷

Getting a Diagnosis

Sicca symptoms are extremely common, and most people with occasional dry eyes or a dry mouth do not have Sjögren’s disease or any serious underlying condition. The diagnostic challenge is figuring out who needs further workup. Evaluation typically starts with questionnaires about symptom severity and objective eye tests, including inflammatory biomarker testing on the tear film. A Schirmer test, which measures how much moisture a strip of paper absorbs from the eye over five minutes, helps distinguish between dryness caused by too little tear production versus dryness from excessive evaporation.¹⁸

When Sjögren’s is suspected, blood tests for specific antibodies and a minor salivary gland biopsy come into play. In a large real-world cohort of over 500 patients presenting with sicca symptoms, salivary gland biopsy proved to be far more diagnostically accurate than the Schirmer test or antibody testing alone.¹⁹ That said, biopsy is invasive, so it is usually reserved for cases where the clinical picture and blood work leave genuine uncertainty.

Treating Dry Eyes

For most people with sicca-related dry eyes, treatment starts with artificial tears. Preservative-free formulations are preferred for frequent use because the preservatives in standard drops can themselves irritate the ocular surface. When artificial tears are not enough, prescription anti-inflammatory drops enter the picture. Lifitegrast, which blocks a specific inflammatory pathway on the eye surface, has shown improvements in both corneal staining scores and patient-reported dryness across multiple large trials and is considered an option for patients who do not respond adequately to lubricating drops alone.²⁰ A systematic review covering 26 trials of 13 different ophthalmic drugs found that none of the large studies hit statistical significance for both a sign and a symptom endpoint simultaneously against a control, highlighting how difficult dry eye is to treat and measure. Lifitegrast came closest, achieving superiority in either a symptom or sign endpoint across multiple large multicenter trials.²¹

Punctal plugs offer a mechanical approach. These tiny devices are inserted into the tear drainage channels to keep tears on the eye surface longer. Compared with artificial tears alone, punctal plugs have shown greater improvement in tear film stability and tear volume, along with meaningful gains in contrast sensitivity under various lighting conditions.²² They are generally well tolerated, though they can occasionally migrate or cause mild irritation.

Managing Dry Mouth

Saliva substitutes come in gels, sprays, and rinses with ingredients that mimic the lubricating and antimicrobial properties of natural saliva. A randomized crossover trial found that both a novel gel and a commercial dry-mouth gel significantly improved oral wetness immediately after application and after two weeks of use, with high patient satisfaction and no adverse effects.²³ The formulations vary widely, from simple cellulose-based thickeners to enzyme-containing products with lactoperoxidase and lysozyme, to thermal spring water sprays.²⁴ No single product has proven decisively better than the others across studies, so patients often try several before settling on one that works for their daily routine.

Pilocarpine, a drug that stimulates the nerves controlling secretion, can boost natural saliva production in people who still have functional gland tissue. However, a head-to-head trial found that artificial tears actually outperformed pilocarpine for tear film stability and symptom improvement, with fewer side effects. Pilocarpine’s systemic cholinergic effects, which can include sweating, flushing, and digestive upset, limit its appeal for mild cases. It tends to be reserved for severe or refractory dryness where the goal is to squeeze more output from remaining gland capacity.²⁵

Beyond products, dental hygiene becomes critically important for anyone with chronic dry mouth. Fluoride rinses and prescription-strength fluoride toothpaste help protect teeth that have lost their saliva shield. Regular dental visits matter more than usual, because cavities can progress rapidly when saliva is absent.²⁶

Systemic Therapies and Their Limitations

For Sjögren’s patients with significant systemic disease, the hope is that suppressing the autoimmune process itself will preserve or restore gland function. The results so far have been mixed at best. Hydroxychloroquine, widely used in lupus and rheumatoid arthritis, failed to improve sicca symptoms in a randomized trial of patients with primary Sjögren’s. After 24 weeks, the proportion of patients meeting the improvement threshold was virtually identical in the drug and placebo groups.²⁷

Rituximab, which depletes B cells, showed modest improvements in physician and patient ratings of disease activity in an open-label trial, and some subjective dryness measures improved, including tongue dryness, thirst, and oral discomfort. But the objective measures that matter most, unstimulated and stimulated saliva flow and tear production by Schirmer test, did not change significantly.²⁸ This disconnect between how patients feel and what the tests show has been one of the frustrating themes in Sjögren’s treatment research. It suggests that subjective dryness involves more than just how much fluid the glands produce: inflammation of the mucosal surfaces, nerve damage, and altered tear or saliva composition all contribute to the sensation of dryness independently of volume.

Regenerative and Experimental Approaches

Because current treatments largely manage symptoms without reversing gland damage, researchers are pursuing regenerative strategies. Three main lines of work are active: gene therapy, stem-cell therapy, and tissue engineering.²⁹

Gene therapy has received particular attention for salivary glands destroyed by radiation. The idea is to introduce the gene for aquaporin-1, a water channel protein, into the remaining gland cells so they can move water more efficiently. In both animal models and early-phase human trials, viral delivery of this gene increased aquaporin protein levels and improved saliva output.³⁰ Stem-cell approaches aim to repopulate damaged glands with cells capable of forming new secretory tissue, while tissue engineering attempts to build gland-like structures on scaffolds that could eventually be implanted.³¹ All of these remain experimental, but they represent a fundamentally different philosophy from symptom management: actually restoring the body’s ability to produce its own moisture.

The Mental Health Side of Chronic Dryness

Sicca symptoms are not life-threatening in most cases, and that can lead clinicians and even patients themselves to underestimate how much chronic dryness affects daily life. A meta-analysis found that about 40 percent of people with dry eye disease met criteria for depression, with roughly double the odds compared with controls. Anxiety was similarly common, affecting about 39 percent, with more than double the odds of prevalence versus people without dry eyes.³² Strikingly, a study comparing patients with sicca symptoms found that fatigue, anxiety, depression, and quality-of-life impairment were similar whether or not the person actually met diagnostic criteria for Sjögren’s disease. In other words, the symptoms themselves carry the psychological burden, regardless of the underlying diagnosis. Anxiety was more common than depression in this population.³³

Sleep quality appears to be another casualty. A cross-sectional study in young adults found that dry eye was closely associated with depression and disturbed sleep, though the relationship with anxiety was less clear in that particular population.³⁴ The practical message is that managing sicca should include screening for mood and sleep problems, because treating the dryness alone may not address the full picture of what is making the person miserable.

When Sicca Appears in Children

Sjögren’s disease in children looks different enough from the adult version that standard adult diagnostic criteria miss most pediatric cases. The hallmark feature in kids is often recurrent parotid gland swelling, sometimes mistaken for mumps or other infections, rather than the classic dry-eye and dry-mouth complaints that adults report. Sicca symptoms may be present but are harder to assess in young patients who may not articulate subtle dryness, and the diagnostic test results can differ from what clinicians expect based on adult patterns.³⁵ Pediatric Sjögren’s remains underrecognized, and a high index of suspicion is needed for any child with unexplained salivary gland enlargement or unusually early dry-eye complaints.

Omega-3 Fatty Acids and Dietary Factors

Dietary supplementation with omega-3 fatty acids has generated interest as a low-risk adjunct for sicca. A randomized, double-blind, placebo-controlled trial in patients with Sjögren’s disease found that those taking fish oil for several months had meaningfully lower dry eye symptom scores, falling into the mild-to-moderate range, compared with the placebo group, which remained in the moderate-to-severe range. Salivary flow also trended toward normalization in the omega-3 group, though that result did not quite reach conventional statistical significance.³⁶ This is a single trial, so the evidence is not yet strong enough to make a definitive recommendation, but omega-3 supplements are generally well tolerated and may be worth discussing with a clinician as part of a broader management plan. Staying well hydrated, using a humidifier in dry environments, and avoiding caffeine and alcohol, both of which have drying effects, are commonsense measures that complement any medical treatment.